VOYA Investment Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10,742
| Closed | -$48.4K | – | 2669 |
|
|
2025
Q2 | $48.4K | Buy |
10,742
+531
| +5% | +$2.39K | ﹤0.01% | 2605 |
|
|
2025
Q1 | $45.2K | Sell |
10,211
-1,484
| -13% | -$8.62K | ﹤0.01% | 2562 |
|
|
2024
Q4 | $91.6K | Sell |
11,695
-738
| -6% | -$8.99K | ﹤0.01% | 2592 |
|
|
2024
Q3 | $163K | Sell |
12,433
-168
| -1% | -$2.13K | ﹤0.01% | 2539 |
|
|
2024
Q2 | $152K | Buy |
12,601
+62
| +0.5% | +$837 | ﹤0.01% | 2557 |
|
|
2024
Q1 | $204K | Sell |
12,539
-3,066
| -20% | -$41.3K | ﹤0.01% | 2447 |
|
|
2023
Q4 | $106K | Sell |
15,605
-22,765
| -59% | -$132K | ﹤0.01% | 2743 |
|
|
2023
Q3 | $209K | Buy |
38,370
+4,024
| +12% | +$23.4K | ﹤0.01% | 2517 |
|
|
2023
Q2 | $233K | Sell |
34,346
-10,893
| -24% | -$81.6K | ﹤0.01% | 2508 |
|
|
2023
Q1 | $227K | Buy |
45,239
+7,594
| +20% | +$31K | ﹤0.01% | 2464 |
|
|
2022
Q4 | $184K | Buy |
37,645
+9,193
| +32% | +$66.8K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $410K | Hold |
28,452
| – | – | ﹤0.01% | 2152 |
|
|
2022
Q2 | $430K | Buy |
28,452
+617
| +2% | +$7.2K | ﹤0.01% | 1928 |
|
|
2022
Q1 | $331K | Buy |
27,835
+14,174
| +104% | +$146K | ﹤0.01% | 2132 |
|
|
2021
Q4 | $221K | Sell |
13,661
-41
| -0.3% | -$876 | ﹤0.01% | 2454 |
|
|
2021
Q3 | $391K | Hold |
13,702
| – | – | ﹤0.01% | 2198 |
|
|
2021
Q2 | $463K | Sell |
13,702
-4,093
| -23% | -$131K | ﹤0.01% | 2140 |
|
|
2021
Q1 | $538K | Buy |
17,795
+1,572
| +10% | +$64.4K | ﹤0.01% | 1990 |
|
|
2020
Q4 | $803K | Buy |
16,223
+2,779
| +21% | +$129K | ﹤0.01% | 1629 |
|
|
2020
Q3 | $516K | Buy |
13,444
+3,028
| +29% | +$121K | ﹤0.01% | 1663 |
|
|
2020
Q2 | $450K | Sell |
10,416
-1,368
| -12% | -$51.7K | ﹤0.01% | 1735 |
|
|
2020
Q1 | $308K | Buy |
11,784
+562
| +5% | +$16.3K | ﹤0.01% | 1900 |
|
|
2019
Q4 | $351K | Buy |
+11,222
| New | +$332K | ﹤0.01% | 2090 |
|
Other funds holding YMAB
VOYA Investment Management's YMAB Position: Q3 2025 in Review
VOYA Investment Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 10,742 shares — an estimated $48.4K sold.
VOYA Investment Management first reported a position in YMAB in Q4 2019 and held it in 23 quarters. The position peaked at $803K in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.
- VOYA Investment Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
- VOYA Investment Management sold 10,742 Y-mAbs Therapeutics shares in Q3 2025, an estimated $48.4K.
- VOYA Investment Management first reported a position in Y-mAbs Therapeutics in Q4 2019 and held it in 23 quarters.
- VOYA Investment Management's Y-mAbs Therapeutics position peaked at $803K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.
Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.